0000000000429315

AUTHOR

Liudmyla Borysenko

showing 3 related works from this author

WITHDRAWN: Association analysis between the early change of serum brain-derived neurotrophic factor (sBDNF) and final change of depression severity d…

2010

This article has been withdrawn at the request of the Editor-in-Chief. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

PharmacologyBrain-derived neurotrophic factormedicine.medical_specialtyPsychiatry and Mental healthNeurologymedicineAntidepressantPharmacology (medical)Neurology (clinical)PsychiatryPsychologyBiological PsychiatryDepression (differential diagnoses)Clinical psychologyGenetic associationEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

P01-92 - Early Changes are Associated with late Changes of BDNF Serum Levels in Inpatients with Major Depression During Short-term Antidepressant Tre…

2010

ObjectivesMean BDNF serum concentration is lower in patients with major depression (MD) as compared to healthy controls. BDNF increases during the course of antidepressant treatment. This increase has been associated with symptom amelioration. The aim of this study was to analyse the relation between early and late BDNF changes during antidepressant treatment.MethodsForty-six patients with MD according to DSM-IV were included for this study. Patients were treated as clinically indicated. Depression severity was assessed by HAMD-17 by trained raters from baseline to week 6 in weekly intervals. Serum at each visit (baseline, V1-V6) was obtained from whole blood after centrifugation with 1.000…

medicine.medical_specialtySerum concentrationPsychiatry and Mental healthEndocrinologynervous systemInternal medicinemedicineAntidepressantIn patientsense organsskin and connective tissue diseasesPsychiatryPsychologyDepression (differential diagnoses)Whole bloodEuropean Psychiatry
researchProduct

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depressio…

2011

Abstract In Major Depressive Disorder, a growing data base suggests that the onset of antidepressants’ action can be detected by improvement of depressive symptoms in the first 10–14 days of treatment. Previous studies showed that the mean concentration of the brain-derived neurotrophic factor (BDNF) in blood increases during antidepressant treatment and positively correlates with amelioration of MDD symptoms. We previously showed an association between very early changes of the serum BDNF concentration and treatment outcome ( Tadic et al., 2011 . Prog Neuropsychopharmacol Biol Psychiatry 35, 415–420). However, no study has yet investigated whether BDNF concentration in plasma increases in …

OncologyAdultMalemedicine.medical_specialtyTime FactorsEnzyme-Linked Immunosorbent AssayCellular and Molecular NeuroscienceYoung AdultNeurotrophic factorsInternal medicineHamdmedicineHumansPsychiatryDepression (differential diagnoses)PharmacologyBrain-derived neurotrophic factorPsychiatric Status Rating ScalesDepressive Disorder MajorInpatientsBrain-Derived Neurotrophic FactorMiddle Agedmedicine.diseaseAntidepressive AgentsROC CurveLinear ModelsAntidepressantBiomarker (medicine)Major depressive disorderAnxietyFemalemedicine.symptomPsychologyNeuropharmacology
researchProduct